General information

In regard to not losing focus, l challenge anyone to read Prof Miles Princes credentials properly in less than 10 minutes, he is an internationally recognized haematologist specializing in oncology with many awards. He turns heads at any haematology event for good reason. Now let's not be confused if he had any inclination that PTX100 didn't have the goods to help people he would be gone in a flash, but as we are aware he has travelled extensively and has also been involved in many interviews and webinars in regard to PTX100. I would imagine we will hear from him soon in regard to his recent trip to the USA with Steven, to my thinking we are lining up for a successful phase 2 trial. My point is let's support the clinical evidence as we are probably through a large part of our investment journey. And l would keep an eye on Cellpryme as l am sure there would be a few interested parties out there looking at it, I agree with a comment recently that SYC has been a bit quieter than usual even in regard to his question answering, l see him as sitting back a bit, but that can be from knowing we are on track and confidence can sneak on board. Time will tell of cause,